Stock GOSS GOSSAMER BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
0.5484 USD -8.60% Intraday chart for Gossamer Bio, Inc. -7.05% -39.90%
05-07 Gossamer Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Chiesi Farmaceutici S.P.A Gossamer Bio, Inc Announces Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GOSSAMER BIO, INC.
Other Biotechnology & Medical Research
-8.60%-7.05%-39.90%-53.13%-97.03% 124M
Bearish
Bearish
Neutral
  1. Stock Market
  2. Equities
  3. GOSS Stock
  4. Charts Gossamer Bio, Inc.
  5. Relative Strength Chart